Top Diagnostics Startups in 2024

Wellist partners with hospitals that truly care about the patient experience to personally guide families to the support they need - from non-medical support services, to hospital resources and information, and personal social support. Our patient and caregiver engagement programs amplify the compassionate care delivered by front line staff to drive patient satisfaction, optimize staff productivity and address barriers to adherence across the care continuum. Wellist’s outstanding contributions have been recognized by organizations including MassTLC (Most Innovative Technology of the Year – Healthcare), Rock Health (Top 50 in Digital Health honoree, Diversity Leadership), American Business Awards (Company of the Year, Silver Stevie – Health Products and Service) and BostInno (50onFire, Health and Medicine winner).

Marigold Health uses novel natural language processing to integrate text-based peer support groups with substance use and behavioral health care, giving stigmatized patients 24/7 access to personalized care, while allowing existing care managers and peer coaches to see a 10x gain in patient capacity.

Every year, about 15 million people worldwide are diagnosed with cancer, not to mention millions more affected by other diseases. In many cases, detecting the disease early can mean the difference between life and death. PathAI uses advanced technology, including machine learning and computer vision, to quickly and accurately detect disease. Once it's been detected, PathAI can also help identify the most promising treatments and therapies, paving the way toward personalized medicine. The team at PathAI isn't just doctors and scientists, but a cross-disciplinary team including technologists, researchers, and designers. It's not enough to just be able to detect disease in a lab – we're working to bring the benefits of earlier disease detection and better treatment to billions, and that's a challenge bigger than what we can learn from the microscope. Join us to help impact disease, in your community and around the world.

Kintsugi is on a mission to scale access to mental healthcare for all. We are developing novel voice biomarker software to detect signs of depression and anxiety from short clips of free form speech. Awarded multiple distinctions for AI technology and recently named one of Forbes’ Top 50 AI companies to watch in 2022, Kintsugi helps to close mental health care gaps across risk-bearing health systems, ultimately saving time and lives. At Kintsugi, we believe that mental health is just as important as physical health. We exist to ensure that everyone who needs mental healthcare has access to the right care at the right time. See mental health differently with Kintsugi. To learn more: kintsugihealth.com

More than a new kind of dialysis machine, Tablo is a new way of thinking about dialysis and the patients who depend on it. Tablo makes it possible to reconsider where dialysis is performed, when dialysis is performed and who can perform it. Tablo opens up opportunities for new in-center patient-powered care models designed to improve the experience while lowering costs for providers.

Freenome is on a mission to empower everyone with the tools they need to detect, treat, and ultimately prevent diseases. If you crave challenges, understudied problems, and the chance to see your work impact the millions of lives touched by cancer, there’s no better place to be. We are committed to our core values of empathy, integrity, and trust enable us to push through challenges, learn from mistakes, and support one another to reach our fullest potential. By applying advanced ML techniques to recent breakthroughs in genomic science, Freenome is developing simple blood tests to detect early-stage cancer and make treatments more effective. The company has raised $238M from investors such as RA Capital, Polaris Partners, Perceptive Advisors, a16z, funds/accounts advised by T. Rowe Price Associates, Inc., GV (fka Google Ventures), Roche Venture Fund, Kaiser Permanente Ventures, American Cancer Society’s BrightEdge Ventures, Data Collective Venture Capital, & Verily Life Sciences.

Karius is a life sciences company focused on generating genomic insights for infectious diseases with a non-invasive karius® test that helps clinicians make rapid treatment decisions. our laboratory is clia-certified and cap-accredited to perform high-complexity clinical laboratory testing. we provide unique genomic insights by detecting microbial cell-free dna (mcfdna) circulating in the bloodstream from pathogens causing an acute infection. proprietary technology efficiently extracts mcfdna directly from blood and depletes the strong human background signal and environmental contaminants. advanced machine learning algorithms allow analysis of complex genomic data in real-time. proprietary reference genome databases are constantly refined as more data becomes available.

Tempus is a technology company that has built an operating system to battle cancer. Tempus enables physicians to deliver personalized cancer care through its interactive analytical and machine learning platform. The company provides genomic sequencing services and analyzes molecular and therapeutic data to empower physicians to make real-time, data-driven decisions. Our goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as we gather more data.

Iterative Health is pioneering the use of artificial intelligence-based precision medicine in gastroenterology (GI), with the aim of helping to optimize clinical trials investigating treatment of inflammatory bowel disease (IBD). We use advanced machine learning and computer vision to interpret endoscopic images along with other types of data, helping clinicians to better assess patients with potential GI problems. This gives practitioners enhanced capabilities in the detection, annotation, disease scoring and treatment of GI related diseases. Iterative Health is initially applying these advances towards standardizing disease severity characterization for inflammatory bowel disease. Ultimately, the company aims to establish more meaningful endpoints to serve as better predictors of both therapeutic response and disease outcomes. The company is headquartered in Cambridge, Massachusetts.

Orange Health is among the fastest-growing diagnostic-tech companies in India. Our vision is to make healthcare seamless for consumers in their homes by enabling doctors to treat their patients in real-time. To do this, we provide 60 min at-home testing for over 2,000 tests and fast results. Consumers love this, and have rated Orange Health 4.8/5 on Google - among the highest diagnostic companies! We combine the latest consumer tech experience with the veracity of high-quality healthcare, giving consumers a mind-blowing experience, where they say 'its easier than ordering a pizza' Launched in Bangalore. Coming soon to your city! Backed by leading investors from across the globe, we have a team of experienced leaders, operators, engineers, medical professionals and more - all of whom love making healthcare better for people like you and us!